Cancer patient preferences for quality and length of life
about
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsPatient preferences in advanced or recurrent ovarian cancer.Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer.Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors.Functional status declines among cancer survivors: trajectory and contributing factors.Can the Toronto Extremity Salvage Score produce reliable results when used online?Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo.Physician and Patient and Caregiver Health Attitudes and Their Effect on Medicare Resource Allocation for Patients With Advanced Cancer.Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiativeDevelopment and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study.Time-Limited Trials of Intensive Care for Critically Ill Patients With Cancer: How Long Is Long Enough?Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effectsA Web-based communication aid for patients with cancer: the CONNECT Study.Effect of patient and patient-oncologist relationship characteristics on communication about health-related quality of life.Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the U.K.: results from the ADVOCATE study.Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of ThailandAddressing Patients' Priorities as a Strategy to Improve Value.Using surveys to calculate disability-adjusted life-year.Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.Multimorbidity's research challenges and priorities from a clinical perspective: the case of 'Mr Curran'.Preferences of colorectal cancer patients for treatment and decision-making: a systematic literature review.Patient-reported outcomes as end points and outcome indicators in solid tumours.Preferences of lung cancer patients for treatment and decision-making: a systematic literature review.Complexity Analysis of Decision-Making in the Critically Ill.Patient-Centered Outcome Measures in Lung Cancer Trials.A randomized controlled trial of a self-regulation intervention for older adults with asthma.Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy.Most impactful factors on the health-related quality of life of a geriatric population with cancer.Values and worries of ovarian cancer patients.Trading years for perfect health: results from the health and retirement study.The longitudinal relationship between quality of life and survival in advanced stage cancer.How do people with chronic kidney disease value cancer-related quality of life?Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid Malignancies.The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer.Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.
P2860
Q27313405-1F2E5499-CC0A-4838-AFD1-315C8E49C60DQ27336251-58743096-2673-47F4-AD7A-243A61290B4DQ33890488-A62DCACE-4756-4665-A80E-0A22EDD3C2A1Q33942677-9A844523-5229-4906-ADC3-1AD2D48043ECQ34145479-D9670311-4EAC-484B-B54B-B8772386D2ACQ34623432-57A19DB5-3BF3-465A-A4EB-A8AE20431E58Q34981729-3683C321-E420-44A8-A250-520F4E000FA3Q35124247-85B4384E-0AD3-4176-8699-139182A328F2Q35611941-24BA99E7-0D9A-44E1-B57E-41A84EAC5FBBQ35878603-DC510905-0BFF-455F-B771-82EB30CC0EF2Q35888144-11A90C4C-1D18-4CF5-A82E-96E77512E08DQ36073427-549B4762-19E4-4DD1-9349-71B0AA8F00BDQ36291898-9A7C6F62-9B70-4D87-A07D-9899B5300C7BQ36463609-7ABB22E8-94A8-426E-9621-03A5D212B396Q36552760-C631CD79-3E87-44A8-A46B-EA65C4D64746Q36554953-51F343C3-01A4-4D3E-9E3C-3EAE9F0D59E3Q36703947-815FD36D-A97C-4883-A210-235B6DB866B9Q36709268-DA9874AD-5B39-428E-9C7C-4624C34382BFQ36924787-E55DEE2F-4918-4AE1-BEA7-31B8640A5DD4Q37296832-234F5E85-E36B-4851-865E-5BD996DB705BQ37535993-A4528B04-5147-4071-BF60-C8B3A6594A6BQ37537391-6B23D30A-8774-4798-9DFA-BFF3E080567AQ37686819-8A81FE8A-40C3-464D-A39E-1503F9B765F5Q38155542-2D4AF22A-C1FB-492E-BDF4-F4DBFD177226Q38212819-BDA846A6-35EE-4DE5-ACDF-5AE4FE610C96Q38371340-936878B0-CCE4-4DBD-9AD0-A04BBE1F876BQ38671666-CCEFB769-F0B8-418E-B029-354C55D1A645Q38792264-673E3840-3A83-49DE-8B02-1C2AFCB5BADFQ38861635-34460DCB-913D-41C2-BE2F-F219B3C9555FQ44170532-E5A7EC24-4644-4ACD-B0AD-63375E737C21Q46201472-99F2C807-B4EF-4E93-B7A6-21DD7B6E00A9Q47293295-91777B62-E5D0-4DD6-B0A7-696811F85795Q47297885-1DF4D7E0-28D8-47A0-86EC-91008D77F7E4Q47372382-E9D8C81F-6D09-4412-AE85-ECA637734D37Q48038841-D9B56575-0DBF-46C3-9320-E4CF144AE5CBQ48563886-F73A36A0-6E55-4E79-97A1-AC52F8E46891Q50053475-63884EC2-52ED-48FA-8EE7-357C5EFF9A71Q50116182-3B8A5334-2B92-429A-9D16-285279E2C79BQ50908904-316C72EE-3CBE-4126-A7FA-4B8816569E91Q53077267-353B495B-7410-4DB2-8410-80958696CD8F
P2860
Cancer patient preferences for quality and length of life
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer patient preferences for quality and length of life
@en
Cancer patient preferences for quality and length of life.
@nl
type
label
Cancer patient preferences for quality and length of life
@en
Cancer patient preferences for quality and length of life.
@nl
prefLabel
Cancer patient preferences for quality and length of life
@en
Cancer patient preferences for quality and length of life.
@nl
P2093
P2860
P356
P1433
P1476
Cancer patient preferences for quality and length of life
@en
P2093
Al B Benson
CONNECT Study Research Group
Daniel P Sulmasy
Donald J Cegala
Joanne S Buzaglo
Kevin P Weinfurt
Linda Fleisher
Michael A Diefenbach
Neal J Meropol
Suzanne M Miller
P2860
P304
P356
10.1002/CNCR.23968
P407
P577
2008-12-01T00:00:00Z